Humasis Co. Ltd. (KOSDAQ:205470)
South Korea · Delayed Price · Currency is KRW 2,835.00
-25.00 (-0.87%)
Oct 12, 2026, 3:30 PM KST
Humasis Revenue
Humasis had revenue of 7.74B KRW in the quarter ending June 30, 2026, a decrease of -12.84%. This brings the company's revenue in the last twelve months to 31.73B, down -15.36% year-over-year. In the year 2025, Humasis had annual revenue of 30.11B with 18.49% growth. That makes Humasis the 32,761st largest company in the world by revenue and 2,085th in South Korea.
Revenue (ttm)
31.73B
Revenue Growth
-15.36%
P/S Ratio
2.02
Revenue / Employee
459.89M
Employees
69
Market Cap
64.12B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 30.11B | 4.70B | 18.49% |
| Dec 31, 2024 | 25.41B | 11.59B | 83.79% |
| Dec 31, 2023 | 13.83B | -457.45B | -97.07% |
| Dec 31, 2022 | 471.27B | 149.44B | 46.44% |
| Dec 31, 2021 | 321.83B | 276.11B | 603.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DRTECH | 126.23B |
| Ray Co., Ltd. | 119.17B |
| Osang Healthcare Co.,Ltd | 96.48B |
| T&R Biofab | 32.73B |
| Access Bio | 23.54B |
| HASS Corp. | 16.08B |
| Sugentech | 9.78B |
| P&S Robotics | 8.55B |